News Algorae Pharmaceuticals Limited

Equities

1AI

AU0000296022

Market Closed - Australian S.E. Other stock markets 06:37:19 06/05/2024 BST			5-day change	1st Jan Change
0.011 ^AUD	0.00%		0.00%	+10.00%

03-08	Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform	MT
02-28	Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform	03-08	MT
Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Algorae Pharmaceuticals Considers Combination Therapy for NTCELL Trial	02-14	MT
Algorae Pharmaceuticals Limited Announces Change of Company Secretary	01-17	CI
Algorae Pharmaceuticals, HL Pharma Partner to Develop Cannabinoid Compound Storage and AI Platform	01-05	MT
Algorae Pharmaceuticals Secures Agreement with HL Pharma	12-28	MT
Algorae, Monash University Collaborate on Pre-Clinical Studies for Cardiovascular Diseases Drug; Shares Plunge 8%	11-23	MT
Algorae Joins CSIRO's Next Generation AI Graduate Program with Grant Funding Participation; Shares Jump 8%	31/10/23	MT
Algorae Pharmaceuticals Enters Partnership for Developing Drug Discovery AI Platform	25/10/23	MT
Algorae Pharmaceuticals Limited announced that it has received AUD 0.001125 million in funding	05/09/23	CI
Living Cell Technologies Collaborating With La Trobe University for Dementia Drug Candidate	01/09/23	MT
Living Cell Technologies Limited has Changed its Name to Algorae Pharmaceuticals Limited	01/09/23	CI
Living Cell Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23	CI
Living Cell Technologies Files Provisional Patent Application for CBD-Combination Drug Candidate for Dementia	26/07/23	MT
Living Cell Technologies May Change Name to Algorae Pharmaceuticals; Shares Rise 6%	11/07/23	MT
Living Cell Technologies Limited Announces Management Changes	02/07/23	CI
Living Cell Technologies Appoints Chief Scientific Officer; Shares Jump 9%	09/06/23	MT
Living Cell Technologies Limited Appoints James A Mckenna as Chief Scientific Officer	08/06/23	CI
Living Cell Technologies Raises Additional Funds from Shortfall Offer	03/05/23	MT
Living Cell Technologies Limited Announces Change of Registered Office	16/04/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Algorae Pharmaceuticals Limited

Equities

1AI

AU0000296022

Summary

Filters